Literature DB >> 222143

Pituitary adrenal recovery following short-term suppression with corticosteroids.

W F Streck, D H Lockwood.   

Abstract

To provide clinical guidelines for the use of high-dose short-term glucocorticoid therapy, we studied recovery of the hypothalamic-pituitary-adrenal axis in 10 normal men following the administration of suppressive doses of prednisone (25 mg twice daily for five days). Cortisol responses to insulin-induced hypoglycemia and synthetic ACTH before treatment were compared with responses two and five days after concluding the prednisone course when adrenal function was not influenced by the presence of exogenous steroid. Two days after prednisone therapy, peak cortisol responses to both hypoglycemia (11.0 +/- 0.9 microgram/dl mean +/- SEM) and synthetic ACTH (13.3 +/- 1.4 microgram/dl) were significantly reduced compared to pretreatment (20.6 +/- 1.6 and 27.3 +/- 2.5 microgram/dl, respectively, p less than 0.001). Five days after concluding the prednisone therapy, peak cortisol response to hypoglycemia had returned to near pretreatment levels although peak cortisol response in the adrenal gland to synthetic ACTH (22.3 +/- 1.1 microgram/dl) remained reduced (p less than 0.05). These data suggest that brief courses of high-dose prednisone therapy may limit the adrenal component of the hypothalamic-pituitary-adrenal response to stress for up to five days.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 222143     DOI: 10.1016/0002-9343(79)90444-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  20 in total

1.  [Perioperative Addisonian crisis].

Authors:  C Martin; T Steinke; M Bucher; C Raspé
Journal:  Anaesthesist       Date:  2012-06-15       Impact factor: 1.041

Review 2.  Corticosteroids and adrenal suppression. Characterising and avoiding the problem.

Authors:  E L Helfer; L I Rose
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

3.  Stimulation of the hypothalamic-pituitary-adrenal axis with the opioid antagonist nalmefene.

Authors:  Eliza B Geer; Rita E Landman; Sharon L Wardlaw; Irene M Conwell; Pamela U Freda
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

Review 4.  Corticosteroid-induced adverse events in adults: frequency, screening and prevention.

Authors:  Laurence Fardet; Abdulrhaman Kassar; Jean Cabane; Antoine Flahault
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

5.  Does dexamethasone suppress the ACTH response in preterm babies?

Authors:  J M Rennie; B Baker; A Lucas
Journal:  Arch Dis Child       Date:  1989-04       Impact factor: 3.791

6.  Global and Targeted Metabolomics Evidence of the Protective Effect of Chinese Patent Medicine Jinkui Shenqi Pill on Adrenal Insufficiency after Acute Glucocorticoid Withdrawal in Rats.

Authors:  Linjing Zhao; Aihua Zhao; Tianlu Chen; Wenlian Chen; Jiajian Liu; Runmin Wei; Jing Su; Xuelan Tang; Keyi Liu; Ran Zhang; Guoxiang Xie; Jun Panee; Mingfeng Qiu; Wei Jia
Journal:  J Proteome Res       Date:  2016-06-20       Impact factor: 4.466

Review 7.  Stopping and restarting medications in the perioperative period.

Authors:  R Cygan; H Waitzkin
Journal:  J Gen Intern Med       Date:  1987 Jul-Aug       Impact factor: 5.128

8.  Recovery of the hypothalamus-pituitary-adrenal axis after short term high dose corticosteroid treatment in neurosurgical practice.

Authors:  P Hedner; G Kullberg; I Bostedt
Journal:  Acta Neurochir (Wien)       Date:  1984       Impact factor: 2.216

9.  Corticosteroids and hypothalamic-pituitary-adrenocortical function.

Authors: 
Journal:  Br Med J       Date:  1980-03-22

Review 10.  Clinical consequences of abrupt drug withdrawal.

Authors:  C F George; D Robertson
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.